miR-21-mediated tumor growth - PubMed (original) (raw)
. 2007 Apr 26;26(19):2799-803.
doi: 10.1038/sj.onc.1210083. Epub 2006 Oct 30.
Affiliations
- PMID: 17072344
- DOI: 10.1038/sj.onc.1210083
miR-21-mediated tumor growth
M-L Si et al. Oncogene. 2007.
Abstract
MicroRNAs (miRNAs) are approximately 22 nucleotide non-coding RNA molecules that regulate gene expression post-transcriptionally. Although aberrant expression of miRNAs in various human cancers suggests a role for miRNAs in tumorigenesis, it remains largely unclear as to whether knockdown of a specific miRNA affects tumor growth. In this study, we profiled miRNA expression in matched normal breast tissue and breast tumor tissues by TaqMan real-time polymerase chain reaction miRNA array methods. Consistent with previous findings, we found that miR-21 was highly overexpressed in breast tumors compared to the matched normal breast tissues among 157 human miRNAs analysed. To better evaluate the role of miR-21 in tumorigenesis, we transfected breast cancer MCF-7 cells with anti-miR-21 oligonucleotides and found that anti-miR-21 suppressed both cell growth in vitro and tumor growth in the xenograft mouse model. Furthermore, this anti-miR-21-mediated cell growth inhibition was associated with increased apoptosis and decreased cell proliferation, which could be in part owing to downregulation of the antiapoptotic Bcl-2 in anti-miR-21-treated tumor cells. Together, these results suggest that miR-21 functions as an oncogene and modulates tumorigenesis through regulation of genes such as bcl-2 and thus, it may serve as a novel therapeutic target.
Similar articles
- MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).
Zhu S, Si ML, Wu H, Mo YY. Zhu S, et al. J Biol Chem. 2007 May 11;282(19):14328-36. doi: 10.1074/jbc.M611393200. Epub 2007 Mar 15. J Biol Chem. 2007. PMID: 17363372 - Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.
Zheng SR, Guo GL, Zhai Q, Zou ZY, Zhang W. Zheng SR, et al. Asian Pac J Cancer Prev. 2013;14(4):2361-6. doi: 10.7314/apjcp.2013.14.4.2361. Asian Pac J Cancer Prev. 2013. PMID: 23725141 - Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.
Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY. Yan LX, et al. Breast Cancer Res. 2011 Jan 10;13(1):R2. doi: 10.1186/bcr2803. Breast Cancer Res. 2011. PMID: 21219636 Free PMC article. - Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.
Muhammad N, Bhattacharya S, Steele R, Ray RB. Muhammad N, et al. Oncotarget. 2016 Sep 6;7(36):58595-58605. doi: 10.18632/oncotarget.11193. Oncotarget. 2016. PMID: 27517632 Free PMC article. Review. - MicroRNAs and their target gene networks in breast cancer.
O'Day E, Lal A. O'Day E, et al. Breast Cancer Res. 2010;12(2):201. doi: 10.1186/bcr2484. Epub 2010 Mar 19. Breast Cancer Res. 2010. PMID: 20346098 Free PMC article. Review.
Cited by
- Edodes Cultured Extract Regulates Immune Stress During Puberty and Modulates MicroRNAs Involved in Mammary Gland Development and Breast Cancer Suppression.
Yasavoli-Sharahi H, Shahbazi R, Alsadi N, Robichaud S, Kambli DB, Izadpanah A, Mohsenifar Z, Matar C. Yasavoli-Sharahi H, et al. Cancer Med. 2024 Oct;13(19):e70277. doi: 10.1002/cam4.70277. Cancer Med. 2024. PMID: 39382253 Free PMC article. - Non-Coding RNAs and Innate Immune Responses in Cancer.
Díaz CR, Hernández-Huerta MT, Mayoral LP, Villegas MEA, Zenteno E, Cruz MM, Mayoral EP, Del Socorro Pina Canseco M, Andrade GM, Castellanos MÁ, Matías Salvador JM, Cruz Parada E, Martínez Barras A, Cruz Fernández JN, Scott-Algara D, Pérez-Campos E. Díaz CR, et al. Biomedicines. 2024 Sep 11;12(9):2072. doi: 10.3390/biomedicines12092072. Biomedicines. 2024. PMID: 39335585 Free PMC article. Review. - The AC010247.2/miR-125b-5p axis triggers the malignant progression of acute myelocytic leukemia by IL-6R.
Xie F, Xu J, Yan L, Xiao X, Liu L. Xie F, et al. Heliyon. 2024 Sep 10;10(18):e37715. doi: 10.1016/j.heliyon.2024.e37715. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39315204 Free PMC article. - Cancer metastases: Tailoring the targets.
Pote MS, Singh D, M A A, Suchita J, Gacche RN. Pote MS, et al. Heliyon. 2024 Aug 2;10(15):e35369. doi: 10.1016/j.heliyon.2024.e35369. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170575 Free PMC article. Review. - Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y, Sun S, Dai W, Xue X, Li N, Yang Y, Shi Z. Leng X, et al. J Pharm Anal. 2024 Jul;14(7):100947. doi: 10.1016/j.jpha.2024.02.001. Epub 2024 Feb 8. J Pharm Anal. 2024. PMID: 39149142 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases